Macropore Inc. IR-Pages
MacroPore Biosurgery Inc. english
MacroPore Biosurgery to Present at the UBS Global Life Sciences Conference
Corporate-news announcement sent by DGAP.
The sender is solely responsible for the contents of this announcement.
——————————————————————————–
MacroPore Biosurgery to Present at the UBS Global Life Sciences Conference
San Diego/Königstein, Ts., September 19, 2003. MacroPore Biosurgery, Inc.
(Frankfurt Stock Exchange: XMP) announced today that Christopher J. Calhoun,
Chief Executive Officer and President, and Marc H. Hedrick, MD, Chief Scientific
Officer, are scheduled to present at the annual UBS Global Life Sciences
Conference on Monday, September 22, 2003 at 8:00 a.m. EST (New York time) or
2:00 p.m. CEST (Germany time). The conference is being held at The Plaza Hotel
in New York City.
Mr. Calhoun and Dr. Hedrick will present the company’s medical device approach
to several of the emerging market opportunities in regenerative medicine.
The public is welcome to listen to and view the presentation through a webcast
by clicking on UBS Global Life Sciences Conference Webcast under “Corporate
Calendar” in the Investor Information section of MacroPore Biosurgery’s website
at www.macropore.com. The webcast will be available live and by replay 24 hours
after the actual presentation. A conference agenda is posted on UBS Investment
Bank’s web site at http://www.ibb.ubs.com. Click on the UBS Investment Bank
conference link and follow the link for details under the Global Life Sciences
Conference heading.
MacroPore Biosurgery, Inc. is a leader in the design, development, and
production of bioresorbable polymer implants for use in a variety of surgical
applications and is pioneering advancement of medicine for surgical therapies
using regenerative cells derived from adipose (fat) tissue. Some products
designed for use in spine, neurosurgical, and musculoskeletal surgeries are
distributed by Medtronic, while other products designed for soft tissue are
distributed through our direct US sales force and an international distribution
network. MacroPore Biosurgery is traded on the Frankfurt Stock Exchange in
Germany under the symbol ‘XMP’. For further information please visit our web
site www.macropore.com.
Edited and published by:
MacroPore Biosurgery, Inc., 6740 Top Gun Street, San Diego, CA 92121, USA
Contact:
Ari E. Bizimis, CFO: Ph. +49-6174-2597-0, Fax: +49-6174-2597-25,
abizimis@macropore.com
Stefanie Bacher, IR: Ph. +49-6174-2597-13, Fax: +49-6174-2597-25,
sbacher@macropore.com
Kim M. Reiff, MC: Ph. +1-858-458-0900, Fax: +1-858-458-0994,
kreiff@macropore.com
end of message, (c)DGAP 19.09.2003
——————————————————————————–
WKN: 940682; ISIN: USU553961025; Index: NEMAX 50
Listed: Geregelter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin-
Bremen, Düsseldorf, Hamburg, Hannover und Stuttgart
190900 Sep 03
Aktuelle News
Aktuelle Berichte
Anstehende Events
Keine Events gefunden
Webcasts
Keine Webcasts gefunden